Glycogen storage disease type VI

From WikiMD's Medical Encyclopedia

(Redirected from Hers disease)

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Glycogen storage disease type VI
Synonyms Hers disease
Pronounce
Specialty Endocrinology, Genetics
Symptoms Hypoglycemia, hepatomegaly, growth retardation
Complications N/A
Onset Infancy
Duration Chronic
Types N/A
Causes Genetic mutation in the PYGL gene
Risks
Diagnosis Genetic testing, liver biopsy
Differential diagnosis Glycogen storage disease type I, Glycogen storage disease type III
Prevention N/A
Treatment Dietary management, cornstarch therapy
Medication
Prognosis Generally good with treatment
Frequency Rare
Deaths


Glycogen storage disease type VI (GSD VI), also known as Hers disease, is a genetic disorder that affects the body's ability to break down glycogen into glucose. This condition is part of a group of disorders known as glycogen storage diseases, which result from defects in the processing of glycogen synthesis or breakdown within the body.

Pathophysiology[edit]

GSD VI is caused by a deficiency in the enzyme glycogen phosphorylase (also known as liver phosphorylase), which is crucial for the degradation of glycogen in the liver. This enzyme deficiency leads to the accumulation of glycogen in the liver, resulting in hepatomegaly (enlarged liver) and other related symptoms.

Genetics[edit]

GSD VI is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the defective gene, one from each parent, to be affected by the disorder. The gene responsible for GSD VI is the PYGL gene, which provides instructions for making the liver phosphorylase enzyme.

Symptoms[edit]

The symptoms of GSD VI can vary widely among affected individuals but often include:

Diagnosis[edit]

Diagnosis of GSD VI typically involves a combination of clinical evaluation, biochemical tests, and genetic testing. Liver biopsy may be performed to measure enzyme activity and confirm the diagnosis.

Treatment[edit]

There is no cure for GSD VI, but treatment focuses on managing symptoms and preventing complications. This may include:

Prognosis[edit]

The prognosis for individuals with GSD VI is generally good, especially with proper management of the condition. Most individuals can lead normal lives with appropriate dietary adjustments and medical care.

See also[edit]

See Also[edit]

References[edit]

External Links[edit]

- Template:Glycogen storage diseases

Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!



Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.